SMTL ID : 3ow4.1 (1 other biounit)

Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

hetero-1-1-mer

Ligands

1 x SMY: (2R)-3-(1H-indol-3-yl)-1-{4-[(5S)-5-methyl-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]piperazin-1-yl}-1-oxopropan-2-amine(Non-covalent)

SMY.1: 19 residues within 4Å: Chain A: L.17, G.18, G.20, G.23, K.24, V.25, A.38, K.40, T.72, M.88, E.89, Y.90, A.91, E.95, M.142, T.152, D.153, F.299 Chain B: R.4 8 PLIP interactions: 7 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:V.25, A:V.25, A:K.40 Hydrogen bonds: A:A.91, A:E.95, A:D.153, B:R.4 Water bridges: A:K.40

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bencsik, J.R. et al., Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-11-10

Peptides

RAC-alpha serine/threonine-protein kinase: A
GSK 3 beta peptide: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

RAC-alpha serine/threonine-protein kinase

GSK 3 beta peptide

Related Entries With Identical Sequence